MiYOSMART D.I.M.S. Technology Lens


MiYOSMART D.I.M.S. Technology Spectacle Lenses

We are now proud to be accredited as one of the practices to fit and supply the new MiyoSmart spectacle lenses with DIMS technology, used to slow down the rate of progression of myopia (short-sightedness).

The myopia population is growing, with more than 2.7 billion people estimated to have myopia in 2030.1

By 2050, over 5 billion people are estimated to be myopic.2

This a growing trend with changing lifestyles as more time is spent on near activities. There is also a growing prevalence of myopia in children.


Being able to have your child’s myopia diagnosed early not only corrects their vision now but can help slow the progression of myopia and preserve their vision and eye health for the future.



How do MiyoSmart lenses work to slow down myopia progression?

 D.I.M.S. Technology

MiyoSmart Lenses use D.I.M.S. technology (Defocus Incorporated Multiple Segments). MiyoSmart is comprised of a clear central zone used to correct myopia. This is surrounded by a zone of multiple defocus segments. These provide clear vision and myopic defocus at the same time at all viewing distances.

This non-invasive management option has been clinically proven to curb myopia progression in average by 59% and slow axial length eye growth in average by 60%.3

How Can I get MiyoSmart for my child?


 Simply contact up to book in for an appointment. Once our optometrist carries out an eye examination to confirm myopia, we can then help you with selecting the correct frame for the MiyoSmart lens.




Disclaimer – MiYOSMART lenses may not be able to address individuals’ conditions due to natural deficiencies illnesses, pre-existing medical conditions and/or advanced age of consumers. The information contained herein is general information and is not intended to constitute medical advice. Please consult your eye care professional for more information prior to the use of MiYOSMART lenses.


1.Holden B.A., Fricke T.R., Wilson D.A., Jong M., Naidoo K.S., Sankaridurg P., Wong T.Y., Naduvilath T.J., Resniko_ S. Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050. American Academy of Ophthalmology. 05/2016, vol.123, no. 5, p.1036–1042. https://doi.org/10.1016/j.ophtha.2016.01.006.
 2Dolgin E. The myopia boom. Nature. 03/2015, vol 519, no 7543, p.276-278
3CH. Defocus Incorporated Multiple Segments (DIMS) spectacle lenses slow myopia progression: a 2-year randomised clinical trial. British Journal of Ophthalmology. Published Online First: 29 May 2019. doi: 10.1136/bjophthalmol-2018-313739